Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Tag: Watch and Wait

smart patients get smart care

ASH 2020: Dr. Christopher Pleyer Discusses the Effect of Bruton Tyrosine Kinase Inhibitors on the Efficacy of Adjuvanted Recombinant Hepatitis B and Zoster Vaccines in Patients with Chronic Lymphocytic Leukemia (CLL)

Dr. Koffman and Dr. Pleyer discuss the findings from two studies that were previously mentioned in earlier stages of the trial that can be found here. Dr. Pleyer looked at immune response rates in CLL patients after receiving the HEPLISAV-B for preventing hepatitis, and the Shingrix vaccine for preventing shingles.

Watch and Wait

By Valerie Vickers – Patient Life in Limbo Lethargy finds expression in a yawn No words or symbols–this heaviness swallows all that is colorful The world in light and dark before diagnosis and after No treatment for dormancy The shadow

Ibrutinib for Watch and Wait? My Story

I was diagnosed with CLL in July 2013. I had a blood test for a sore throat. The lymphocyte count was only 5 – borderline – but it was a shock. My wife and I met with the oncologist who told us we were on “watch and wait”, with blood tests every six months. I had no lymph nodes and my hemoglobin and platelets were fine. But like most patients we weren’t entirely comfortable with watch and wait.

CLL: When to Watch and Wait and When to Start Treatment

Updated on: 8/9/2023 Takeaway Points: Quiz (Where we get to play doctor) Nine months after diagnosis, a fellow patient with CLL tells you that his WBC (white blood cell count) is 49,000 with an ALC (absolute lymphocyte count) of 42,000.